Latest Interviews
Showing 346–360 of 1,442 transcripts.
Clear all filters- Milken Institute58 min
Innovation for All: Strategies for Maximizing Impact | Future of Health Summit 2024
Matthew Herper, Jay Bradner, Debi Brooks, Lisa D. Earnhardt, Elizabeth Fowler, Marc Samuels
This event synthesized breakthroughs in Parkinson's biomarker detection, the genetic discovery of obesity-protective alleles, and strategies to expand medical device access for underserved populations. Industry leaders and regulators discussed how these scientific advances confront systemic barriers in delivery and reimbursement, particularly regarding the high costs of gene therapies and the misalignment of current billing models with preventative care. The consensus emphasized that future progress depends on shifting focus from pure biological innovation to collaborative frameworks that ensure scalable manufacturing, equitable access, and payment reforms based on patient outcomes.
- Milken Institute1h 0m
Why Younger People Are Getting Cancer and What We Can Do About It | Future of Health Summit 2024
Dylan Scott, Karen Knudsen, Harlan Levine, Mohit Manrao, Kimryn Rathmell, AmirAli Talasaz
A comprehensive 24-million-person study spanning two decades reveals that 17 of 34 major cancer types are rising significantly among Millennials and Gen X, prompting the American Cancer Society to lower screening thresholds despite critical barriers in adoption and access. To address this "tsunami" of young survivors facing unique fertility, financial, and care challenges, the field is transitioning toward liquid biopsy innovations and multidisciplinary "living" guideline frameworks to bridge the gap between community providers and academic centers. While precision medicine and expanded immunotherapy trials offer hope for improved survival, the crisis persists due to outdated insurance models, systemic disparities, and a significant lag between emerging scientific evidence and updated clinical protocols.
- Milken Institute54 min
Connecting the Dots for Women's Health: Innovation, Access, & Care | Future of Health Summit 2024
Ruth Reader, Sandra Brooks, Trish Costello, Jenica Patterson, Ana Maria Ramirez, Tammy Sun
As of last week, ARPA-H has obligated $113 million in federal funding to support women's health research through Spark and Launchpad awards targeting conditions like Alzheimer's, endometriosis, and maternal mortality. This investment coincides with a 300% surge in venture capital for the sector since 2018, driving innovations in male contraception and non-pharmacological treatments despite persistent racial disparities and access barriers. While bipartisan funding provides short-term stability, experts warn that evolving legal landscapes regarding abortion and the politicization of data privacy pose significant risks to future reproductive health outcomes.
- Milken Institute40 min
Bot or Not?: AI in Health Care | Future of Health Summit 2024
Richard Lui, Dipanwita Das, John Halamka, Vidya Raman-Tangella
Industry leaders including Sociero CEO Dipanita Das, Mayo Clinic President Dr. John Halamka, and Teladoc CMO Vidya Rahman convened to argue that while technical barriers to healthcare AI have dissolved, cultural resistance and data heterogeneity now impede transformative progress. The panel highlighted critical successes such as Mayo Clinic's ability to detect Stage Zero pancreatic cancer and Teladoc's use of generative AI for personalized patient engagement, underscoring the necessity of embedding real-world evidence and clinical validation into care pathways. Ultimately, the group urged a strategic shift from adopting technology for novelty to solving specific operational problems, calling for a global federated data network to achieve a preventative "precision health" vision for four billion people by 2030.
- Milken Institute1h 0m
Building Safer Communities: Health Approaches to Gun Violence Prevention | Future of Health Summit
Omer Awan, Stefanie Feldman, Angela Ferrell-Zabala, Alex M. Johnson, Zachary Meisel, Chethan Sathya
Public health experts and university administrators gathered to strategize a shift toward community-based violence intervention focused on economic opportunity and data-driven safety for youth. The session highlighted a bipartisan legislative push for federal funding while emphasizing the need to bridge trust gaps with marginalized communities through localized, peer-led development models. Key stakeholders set a September 4th deadline for public-private collaboration and outlined plans to launch long-term investment initiatives that integrate food security and systemic change to address social determinants of health.
- Milken Institute31 min
Opening Remarks | Future of Health Summit 2024
The Milken Institute Future of Health Summit 2024 convenes over 200 global leaders across philanthropic, scientific, and governmental sectors to address critical health challenges like aging populations, rising chronic disease rates, and systemic access barriers. Featuring the theme "Partnering for Better Health," the event focuses on collaborative solutions to bridge the gap between massive healthcare investments and poor national outcomes, including a strategic shift from treatment to prevention. Discussions will examine how AI, biomedical innovation, and inclusive clinical trials can accelerate medical development while ensuring equitable access to care for diverse demographics.
- Milken Institute32 min
A Conversation with CDC Director Mandy Cohen | Future of Health Summit 2024
CDC Director Wendy Cohen reaffirmed the agency's commitment to core public health missions while detailing infrastructure upgrades including national wastewater monitoring and expanded emergency room data visibility to track emerging threats like avian flu. She highlighted a significant 13% year-over-year decline in fatal overdoses driven by new care strategies, though she warned that proposed budget cuts to suicide prevention programs pose severe risks to those under 50. Addressing recent vaccine skepticism and global measles surges, Cohen emphasized the urgent need to integrate healthcare delivery with public health operations to overcome funding gaps and restore public trust.
- Milken Institute22 min
A Conversation with FDA Commissioner Robert Califf | Future of Health Summit 2023
Robert Califf, Conrad Kiechel, Esther Krofah
FDA Commissioner Robert Califf highlighted a critical gap in U.S. health outcomes, noting that despite high spending, life expectancy has fallen to 76.4 years while fragmented post-market evidence systems fail to answer key treatment questions. To address this, Califf proposed a unified ecosystem involving the CMS, NIH, and FDA to leverage real-world data and AI for generating rigorous post-approval evidence while incentivizing clinicians to participate in large-scale research. Additionally, the agency plans to combat persistent public distrust and medical misinformation through plain-language communication and a broad coalition of academic, industry, and community partners.
- Milken Institute16 min
A Conversation with US Senator, Amy Klobuchar, Minnesota | Future of Health Summit 2023
Senator Chris Coons leveraged his father's diagnosis of late-onset Alzheimer's to champion bipartisan legislation that has increased Alzheimer's research funding to over $3.7 billion while securing NIH grants for clinical trials. Beyond medical advocacy, Coons and Senator Josh Hawley introduced bills to ban deepfake election ads and collaborate with colleagues to integrate AI into healthcare without replacing human caregivers. This work aims to address the "sandwich generation" crisis and ensure technological innovation balances national security with the protection of voter integrity and workforce equity.
- Milken Institute33 min
Global Health: Connectiveness for Better Outcomes | Asia Summit 2024
Esther Krofah, Mina Hamoodi, Ganen Sarvananthan, Tom Snow
Tom Snow's Snow Research Foundation, Lina Al Jaber's Mubadala, and Ganon Savaranthan's TPG Capital Asia outlined distinct strategies to accelerate healthcare innovation across the region through a combined focus on early-stage equity funding, sovereign wealth market expansion, and value-based service delivery. These leaders emphasized a shift from traditional grant models toward partnership-driven approaches that leverage local expertise to address Asia's unique demographic challenges, including rapid aging and the need for scalable clinical trials. By integrating advanced technologies like AI and electronic medical records with targeted investments in immunology, women's health, and infrastructure, the panelists aim to bridge the critical gap between academic discovery and commercial bedside application within one to two years.
- Milken Institute49 min
Can Psychedelics Improve Mental Health? With C. Angermayer & Uma Thurman | Global Conference 2021
C. Angermayer, Uma Thurman, Christian Angermayer, Robert Mancini
German biotech investor Christian Angermeyer founded Atai Life Sciences to develop psychedelic therapeutics capable of treating over one billion people suffering from mental health conditions that current standard medications often fail to address. By targeting the brain's Default Mode Network to induce neuroplasticity, Angermeyer's pipeline includes non-addictive compounds like psilocybin and MDMA intended to be administered under strict medical supervision rather than for recreational use. The strategic goal is to reclassify these substances through rigorous FDA protocols to resolve widespread anxiety, addiction, and trauma while eventually fostering broader societal reconciliation as medical efficacy becomes undeniable.
- Milken Institute45 min
The Private Equity Edge | Global Investors' Symposium Mexico City 2024
Carolina Millan, Luis Cervantes, Pablo Coballasi, Christine Kenna, Scott Sobel
General Atlantic and regional investors are leveraging a $4 billion annual venture capital market in Latin America, characterized by a 20x growth since 2010 and a strategic shift toward local capital and women-led enterprises. With private valuations down 65% from 2021 peaks, the sector is capitalizing on nearshoring trends and a $50 billion energy transition gap through diversified exit strategies involving IPOs, secondaries, and active M&A. Looking toward a 2026 liquidity window, the investment community anticipates sustained growth driven by Mexico's engineering talent, expanding pension funds, and a stable regulatory environment under President Claudia Sheinbaum's administration.
- Milken Institute46 min
Shifting from Reactive to Proactive Health Care | Asia Summit 2024
Sung Hee Choe, Binayak Dutta, Amit Kakar, Lance Little, Simranjit Singh, Tracey Woon, Simran Singh
Facing a healthcare expenditure projected to surpass defense spending by 2030, Singapore launched the Healthier SG initiative to shift focus from acute treatment to preventive care managed by general practitioners. This strategic pivot addresses critical gaps in chronic disease management and early cancer detection by leveraging government incentives, while innovators like Roche Diagnostics and Novo Holdings introduce self-sampling technologies and AI diagnostics to overcome behavioral barriers and workforce shortages. Despite these advances, stakeholders emphasize that sustained progress requires resolving regulatory friction, aligning financial incentives for prevention, and accelerating patient adoption through targeted behavioral nudges and dynamic insurance models.
- Milken Institute31 min
A Conversation with Gwyneth Paltrow | Milken Institute Global Conference 2022
Gwyneth Paltrow, Julia Boorstin
Founded by CEO Gwyneth Paltrow, the diversified lifestyle conglomerate Goop has secured $135 million in funding to reach a $400 million valuation by monetizing an audience through its proprietary "contextual commerce" model. The company integrates omnichannel revenue streams ranging from Netflix programming and cloud kitchen food delivery to a luxury beauty line and fashion drops, leveraging Paltrow's cultural influence to normalize taboos while expanding into international markets like Japan. Operating as a scalable corporate entity with a hybrid work strategy, Goop continues to prioritize service-first engagement to drive sales across its global portfolio while positioning itself for a future exit via IPO or acquisition.
- Milken Institute42 min
Fulfilling FinTech’s Promise | Global Investors' Symposium Mexico City 2024
Michael Piwowar, Adolfo Babatz, Marlene Garayzar, Heath Tarbert, Mike Pivovar, Rodrigo Bettini
Moderated by Michael Pivovar of the Milken Institute, the panel "Fulfilling Fintech's Promise" analyzed Mexico's cash-dominated economy and its barriers to financial inclusion through the lens of industry leaders Adolfo, Marlene, and Heath. Panelists from Clip, Story, and Circle detailed how digital solutions are overcoming oligopolistic market structures and high regulatory hurdles to provide credit, savings, and efficient cross-border remittances to the unbanked. The discussion concluded by advocating for robust antitrust enforcement and proactive regulatory engagement to accelerate Mexico's transition toward a competitive, on-chain financial ecosystem.